U. Masanek et al., RESISTANCE PROTEINS IN HUMAN KIDNEY, BREAST, OVARIAN AND LUNG-CARCINOMA - A COMPARATIVE-ANALYSIS, Oncology Reports, 2(1), 1995, pp. 41-44
The expression of P-glycoprotein (P-170), glutathione S-transferase-pi
(GST-pi), dihydrofolate reductase (DHFR) and thymidylate synthase (TS
) was analyzed immunohistochemically in human tumors of different orig
in. The resistance proteins were expressed at varying degree: all kidn
ey carcinomas (n=25), 40 of 56 non-small cell lung carcinomas (NSCLC)
(71%), 8 of 15 ovarian carcinomas (53%), 5 of 11 breast carcinomas (46
%) and 3 of 14 small cell lung carcinomas (SCLC) (21%) expressed more
than one resistance protein. A comparison of the immunohistochemical d
ata with the clinical response rates as reported in literature, demons
trates an evident correlation between the number of resistance protein
s and the clinical outcome.